(Français) Sida: L’Afrique du Sud Lance des Médicaments Antirétroviraux a Prix Record

ORIGINAL LANGUAGES, 15 Apr 2013

François Dabis, RFI – TRANSCEND Media Service

Il y aurait 6 millions de séropositifs en Afrique du Sud, soit plus d’une personne sur 10. Le gouvernement réagit en lançant un programme de distribution de médicaments antirétroviraux à un prix record de 89 rands mensuels soit 7,5 euros. C’est le résultat d’un accord entre plusieurs laboratoires pharmaceutiques, dont certains de génériques qui permettrait la prise en charge de 2,5 millions de personnes dans les deux prochaines années.

« L’Afrique du Sud a décidé depuis quelques années d’avoir un programme très ambitieux de traitement de sa population vivant avec le VIH. Utiliser aujourd’hui les meilleures combinaisons et les plus simples, à savoir un comprimé par jour est devenu possible grâce à des prix extrêmement bas. C’est ce que l’Afrique du Sud vient de négocier avec les compagnies pharmaceutiques. »

_________________________

François Dabis : Professeur d’épidémiologie et de santé publique à l’université de Bordeaux 2.

Go to Original – rfi.fr

Share this article: email mastodon facebook 🔗 copy link

DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.

Comments are closed.